Welcome to Our Medtech Talk Podcast Channel

Too often we define the Medtech sector by the number of dollars raised, IPOs helped or companies sold. But the focus neglects the very foundation of the sector - the People. Join the Medtech Talk Podcast each week to hear from entrepreneurs, investors and executives who spend their days developing the tools that make sick people well and health care more efficient.

VytronUS Combining Powers of Ultrasound, Robotics to Treat Afib

November 30, 2017

John Pavlidis, president and CEO of VytronUS, has built a strong resume leading and selling Medtech start-ups. Now the self-described engineering “nerd” is leading VytronUS, a start-up combining the powers of imaging, ablation, and robotics to create a powerful new tool that can elevate the precision in the electrophysiology lab. In this Medtech Talk Podcast, Pavlidis tells what lessons he learned jumping from a large company (Siemens) to serving as CEO of a small company. He also explains the great potential for VytronUS, which is developing a catheter-based endocardial ablation platform based on Low-Intensity Collimated Ultrasound (LICU). LICU can produce high-resolution maps of cardiac anatomy and deliver ablative energy without touching the tissue.

John Pavlidis

President & CEO

Vytronus Inc

John joined VytronUS in early 2015 as the President and CEO. John has more than twenty-five years of medical device experience. Prior to VytronUS, John was President and CEO of Endoscopic Technologies, Inc. a leader in minimally invasive and endoscopic cardiac ablation, valve repair or replacement, and coronary bypass surgical technology. Endoscopic Technologies was acquired by AtriCure in late 2013. Previously, John served as President and CEO of R2 Technology Inc., the pioneer and leader in computer-aided detection of breast cancer, until Hologic Inc. acquired the company in 2006. Before joining R2 Technology, John was the President of the Ultrasound group at Siemens Healthcare for five years, where he led the acquisition and integration of Acuson Inc. and subsequent growth to $1 Billion revenue. John earned a B.S. in Biomedical Engineering from Rensselaer Polytechnic Institute and an M.S. in Engineering Sciences from the Thayer School of En gineering at Dartmouth College.